This was a retrospective non-comparative, interventional case series of 50 eyes in 50 patients with symptomatic PBK who underwent CXL (epithelium-off). Central corneal thickness (CCT), pain score, best corrected visual acuity (BCVA), and corneal transparency were recorded at baseline; at day seven, day 15; and one, three, and six months after the CXL. The mean pain score decreased from 8.1+/-0.6 at presentation to 2.1+/-0.7 on day seven (P=0.0001). Regression was seen in pain scores over six months (5.3+/-1.5). The mean CCT decreased from a preoperatively 724.8+/-78.4 to 694.9+/-77.9um by the end of the first month (P=0.0001) and remained stable at subsequent follow-up. The BCVA improved from log MAR) 2.0+/-0.5 preoperatively to log MAR 1.8+/-0.5 by the end of the first month (P=0.001). The subsequent follow-up showed a progressive deterioration in the BCVA to the preoperative levels at six months. Corneal bullae recurred in 44% (22 eyes) at six months after an initial disappearance. A significant improvement in the BCVA and a lack of recurrence of bullae were significantly associated with a thinner CCT on presentation (<700um). The authors conclude that CXL in symptomatic PBK temporarily improved pain without providing long-term improvement in the BCVA. Case selection is important with more effect seen in patients with a thinner CCT at presentation. Other reports in addition to this support the use of CXL as a useful intervention as a palliative procedure rather than for visual rehabilitation. Those with thicker CCT will have greater irreversible stromal changes and perhaps this is why the authors report a better outcome in those with thinner corneas. It may be an intervention to consider prior to a Gunderson’s flap in a painful blind eye due to bullous keratopathy.

Outcomes of corneal collagen crosslinking (CXL) in pseudophakic bullous keratopathy (PBK).
Ray NSS, Maharana PK, Sehra SV, et al.
Share This
Sharmina Khan

Moorfields Eye Hospital, London, UK

View Full Profile